ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1165

The Development of an Interdisciplinary Treatment Program for Fibromyalgia in a Tertiary Medical Center Focused upon Rheumatology and Internal Medicine

Jessica Gehin1, Andy Abril2,3, Fernando Rivera4, Benjamin Wang3 and Barbara Bruce1, 1Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, 2Mayo Clinic, Jacksonville, FL, 3Division of Rheumatology, Mayo Clinic, Jacksonville, FL, 4Division of Consultative and Diagnostic Medicine, Mayo Clinic, Jacksonville, FL

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fibromyalgia and interdisplinary

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Education - ARHP Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Fibromyalgia syndrome (FMS) appears to be undertreated despite the mounting evidence to support the efficacy of interdisciplinary treatment. Why are patients not receiving effective care? Practice needs included a lack of standardized assessment and treatment for patients with Fibromyalgia, inefficient management of patients being referred to Rheumatology for Fibromyalgia creating less availability of Rheumatologists on the consult service as well as reducing availability of appointments for other rheumatologic patients needed for resident teaching as well as low satisfaction for physicians employed in the care of these patients without the support of an interdisciplinary team. The present study was designed to describe the development of a successful interdisciplinary treatment program for Fibromyalgia patients and provide clinical information on the first 600 patients treated in this program between October 2014 and April 2016.

Methods:  The collaborative structure of the interdisciplinary team and the goals of the program are illustrated. Patients referred to a tertiary medical center for evaluation of fibromyalgia symptoms, which were subsequently diagnosed with FMS by meeting the 2010 ACR criteria, enrolled in a 2-day interdisciplinary treatment program, served as subjects in this study. All patients in this study met the ACR Classification Criteria for Fibromyalgia. Patients completed the Fibromyalgia Impact Questionnaire – Revised (FIQR), the Center for Epidemiological Studies Depression Scale (CES-D), and the Pain Catastrophizing Scale (PCS) at the time of admission to the program. Patients were seen in a collaborative care model with trained psychiatric nurses and physicians for diagnosis and then received cognitive behavioral strategies and education in a 2-day course led by health psychologists and nurses.

Results:  Physician feedback revealed that at one year, rheumatology consults had significantly greater availability, a varied patient population was now being seen in the residency program, and physician satisfaction was very high. Of the 600 patients that participated in the Fibromyalgia Treatment Program, the average age of patients was 49 years with a range from 17 to 92. The majority was female (90%). Duration of fibromyalgia symptoms on average was 10 years at the time of referral. Forty-three percent of the patients were regional, 32% national, 24% local and 1% international. The FIQR results revealed severe levels of impairment (62.08); CESD scale scores indicated significant depressive symptoms with an average score of 26; and PCS scores were at elevated levels of pain catastrophizing with an average score of 25. Patient and family satisfaction was uniformly high.

Conclusion:  A successful interdisciplinary program can be developed in a medical practice. The improvement in physician and patient satisfaction in this care model is substantial. Large numbers of patients with Fibromyalgia are still not receiving interdisciplinary care locally producing continued difficulties in functioning and psychological distress.


Disclosure: J. Gehin, None; A. Abril, None; F. Rivera, None; B. Wang, None; B. Bruce, None.

To cite this abstract in AMA style:

Gehin J, Abril A, Rivera F, Wang B, Bruce B. The Development of an Interdisciplinary Treatment Program for Fibromyalgia in a Tertiary Medical Center Focused upon Rheumatology and Internal Medicine [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-development-of-an-interdisciplinary-treatment-program-for-fibromyalgia-in-a-tertiary-medical-center-focused-upon-rheumatology-and-internal-medicine/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-development-of-an-interdisciplinary-treatment-program-for-fibromyalgia-in-a-tertiary-medical-center-focused-upon-rheumatology-and-internal-medicine/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology